Plasmalogen Deficiency and Overactive Fatty Acid Elongation Biomarkers in Serum of Breast Cancer Patients Pre- and Post-Surgery—New Insights on Diagnosis, Risk Assessment, and Disease Mechanisms

MLA

Satomi Tomida, et al. “Plasmalogen Deficiency and Overactive Fatty Acid Elongation Biomarkers in Serum of Breast Cancer Patients Pre- and Post-Surgery—New Insights on Diagnosis, Risk Assessment, and Disease Mechanisms.” Cancers, Aug. 2021. EBSCOhost, https://doi.org/10.3390/cancers13164170.

APA

Satomi Tomida, Dayan B. Goodenowe, Ritei Uehara, Koichi Sakaguchi, Tetsuya Taguchi, Midori Morita, Etsuko Ozaki, Nagato Kuriyama, Teruhide Koyama, & Yasuyo Yamazaki. (2021). Plasmalogen Deficiency and Overactive Fatty Acid Elongation Biomarkers in Serum of Breast Cancer Patients Pre- and Post-Surgery—New Insights on Diagnosis, Risk Assessment, and Disease Mechanisms. Cancers. https://doi.org/10.3390/cancers13164170

Chicago

Satomi Tomida, Dayan B. Goodenowe, Ritei Uehara, Koichi Sakaguchi, Tetsuya Taguchi, Midori Morita, Etsuko Ozaki, Nagato Kuriyama, Teruhide Koyama, and Yasuyo Yamazaki. 2021. “Plasmalogen Deficiency and Overactive Fatty Acid Elongation Biomarkers in Serum of Breast Cancer Patients Pre- and Post-Surgery—New Insights on Diagnosis, Risk Assessment, and Disease Mechanisms.” Cancers, August. doi:10.3390/cancers13164170.